Erstellt von fchar99
Moleculin Biotech Inc diskutieren
Moleculin Biotech Inc
WKN: A2QQM0 / Symbol: MBRX / Name: Moleculin Biotech / Aktie / Pharmazeutika / Micro Cap /
0,41 €
1,53 %
Moleculin Biotech, Inc. (NASDAQ: MBRX) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $4.00 price target on the stock.
Ratings data for MBRX provided by MarketBeat
Moleculin Biotech, Inc. (NASDAQ: MBRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for MBRX provided by MarketBeat
Moleculin Biotech, Inc. (NASDAQ: MBRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for MBRX provided by MarketBeat
Moleculin Biotech (NASDAQ:MBRX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for MBRX provided by MarketBeat
Moleculin Biotech (NASDAQ:MBRX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for MBRX provided by MarketBeat
Neueste Beiträge
Roth_Capital in Gran Tierra Energy Inc. diskutieren